Motion · S4M-15334 · 14 Jan 2016

Major Milestone in Tackling Leukaemia

Lodged by Kenny MacAskill Standard Motion 29 supporters

The motion

That the Parliament commends the work of Professor Kamil R Kranc, Cancer Research UK Senior Fellow at the MRC Centre for Regenerative Medicine at the University of Edinburgh, and his team; understands that Professor Kranc is the lead author of a report that identifies two genes that could halt the formation of cancerous stem cells in an aggressive form of leukaemia, acute myeloid leukaemia (AML); believes that 2,400 people are diagnosed with AML in the UK each year, and fewer than one in five will survive longer than five years; understands that the new knowledge will be harnessed to develop curative therapies that eliminate leukaemic stem cells, which are the underlying cause of AML; congratulates the researchers at the University of Edinburgh on what has been hailed as a major milestone in efforts to combat leukaemia, and commends Cancer Research UK as a major funder of this research.

Supporters (29)

Source: the Scottish Parliament motions and amendments record.